Immunoglobulin A-producing cells mediate the clinical benefits of metformin via interleukin-10
Guo et al. show that metformin enhances intestinal IgA immunity via gut microbiota and increases gut antigen-specific IgA-producing IL-10+ cells in the liver and VAT. IL-10 from these cells mediates the clinical benefits of metformin.
